{"mainPropery":{"diseaseId":735,"diseaseName":"Antisynthetase syndrome","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/735/antisynthetase-syndrome","synonyms":["Anti-Jo1 syndrome","AS syndrome"],"synonyms-with-source":[{"name":"Anti-Jo1 syndrome","source":"OrphaData.Org"},{"name":"AS syndrome","source":"OrphaData.Org"}],"identifiers":[{"identifierType":"ORPHANET","identifierId":"81"},{"identifierType":"UMLS","identifierId":"C2609059"}]},"diseaseCategories":[{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases","source":"Orphanet"}],"organizations":[{"resourceID":103,"resourceName":"Arthritis Foundation","abbreviation":"","address1":"1355 Peachtree St. NE","address2":"6th Floor","address3":"","address4":"","address5":"","city":"Atlanta","state":"GA","zip":"30309","country":"United States","phone":"+1-404-872-7100","tty":"","tollFree":"1-844-571-HELP (4357)","fax":"","email":"","url":"https://www.arthritis.org","freeText":""},{"resourceID":189,"resourceName":"The Myositis Association","abbreviation":"TMA","address1":"1940 Duke Street","address2":"Suite 200 ","address3":"","address4":"","address5":"","city":"Alexandria","state":"VA","zip":"22314","country":"United States","phone":"+1-703-299-4850","tty":"","tollFree":"1-800-821-7356","fax":"+1-703-535-6752","email":"TMA@myositis.org","url":"https://www.myositis.org/","freeText":""},{"resourceID":241,"resourceName":"The Arthritis Society","abbreviation":"","address1":"393 University Avenue, Suite 1700","address2":"Toronto, Ontario M5G 1E6","address3":"","address4":"","address5":"","city":"","state":"","zip":"","country":"Canada","phone":"+1-416-979-7228","tty":"","tollFree":"1-800-321-1433","fax":"+1-416-979-8366","email":"info@arthritis.ca","url":"https://arthritis.ca/","freeText":""},{"resourceID":933,"resourceName":"American Autoimmune Related Diseases Association","abbreviation":"AARDA","address1":"19176 Hall Road, Suite 130","address2":"","address3":"","address4":"","address5":"","city":"Clinton Township","state":"MI","zip":"48038","country":"United States","phone":"586-776-3900","tty":"","tollFree":"800-598-4668","fax":"586-776-3903","email":"aarda@aarda.org","url":"https://www.aarda.org/","freeText":""},{"resourceID":3658,"resourceName":"Myositis UK","abbreviation":"","address1":"146 Newtown Road","address2":"Woolston","address3":"Southampton","address4":"SO19 9HR","address5":"","city":"","state":"","zip":"","country":"United Kingdom","phone":"023 8044 9708","tty":"","tollFree":"","fax":"","email":"msg@myositis.org.uk","url":"https://www.myositis.org.uk/","freeText":""}],"resource descriptions":[{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=PureSearch&db=pubmed&details_term=Antisynthetase%5BTitle%5D%20AND%20syndrome%5BTitle%5D%20AND%20hasabstract%5Btext%5D' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Antisynthetase syndrome. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Antisynthetase+syndrome%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Antisynthetase syndrome. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='https://rarediseases.org/rare-diseases/antisynthetase-syndrome/' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=81' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1550,"resourceId":2178,"resourceName":"DermNet New Zealand","descriptionText":"<a href='http://dermnetnz.org/immune/antisynthetase.html' target='_blank'>DermNet NZ</a> is an online resource about skin diseases developed by the New Zealand Dermatological Society Incorporated. DermNet NZ provides information about this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/Orphanet:81' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":683,"questionText":"What is antisynthetase syndrome?","answerText":"<strong>Antisynthetase syndrome</strong> is a chronic <a href=\"http://www.nlm.nih.gov/medlineplus/autoimmunediseases.html\" target=\"_blank\">autoimmune condition</a> that affects the muscles and various other parts of the body. The signs and symptoms can vary but may include muscle inflammation (myositis), polyarthritis (inflammation of many joints), <a href=\"http://www.nlm.nih.gov/medlineplus/interstitiallungdiseases.html\" target=\"_blank\">interstitial lung disease</a>,&nbsp;<span>thickening and cracking of the hands,</span><span>&nbsp;</span>and <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000412.htm\" target=\"_blank\">Raynaud phenomenon</a>. The exact underlying cause is unknown; however, the production of autoantibodies (<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002223.htm\" target=\"_blank\">antibodies</a> that attack normal cells) that  attack certain <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002353.htm\" target=\"_blank\">enzymes</a> in the body called 'aminoacyl-tRNA synthetases' appears to be linked to the cause of the syndrome. These autoantibodies may arise after viral infections, or patients may have a&nbsp;<a href=\"http://ghr.nlm.nih.gov/handbook/mutationsanddisorders/predisposition\" target=\"_blank\">genetic predisposition</a>. Treatment is based on the signs and symptoms present&nbsp;in each person but may include <a href=\"http://www.nlm.nih.gov/medlineplus/steroids.html\" target=\"_blank\">corticosteroids</a>, immunosuppressive medications, and/or <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/007448.htm\" target=\"_blank\">physical therapy</a>.[9477][9478][9479][11593]","dateModified":"2017-03-10T00:00:00"},"basicQuestions":[{"questionId":698,"questionText":"What are the signs and symptoms of antisynthetase syndrome?","answerText":"The signs and symptoms of antisynthetase syndrome vary but may include:[9476][9477][9478]\r\n<ul>\r\n    <li>Fever</li>\r\n    <li>Loss of appetite</li>\r\n    <li>Weight loss</li>\r\n    <li>Muscle inflammation (<a href=\"http://www.nlm.nih.gov/medlineplus/myositis.html\" target=\"_blank\">myositis</a>)</li>\r\n    <li>Inflammation of multiple joints (polyarthritis)</li>\r\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/interstitiallungdiseases.html\" target=\"_blank\">Interstitial lung disease</a> (ILD) causing shortness of breath, coughing, and/or <a href=\"http://www.nidcd.nih.gov/health/voice/Pages/dysph.aspx\" target=\"_blank\">dysphagia</a></li>\r\n    <li>Mechanic's hands (thickened skin of tips and margins of the fingers)</li>\r\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000412.htm\" target=\"_blank\">Raynaud phenomenon</a></li>\r\n</ul>\r\n<p>Some studies suggest that affected people may be at an increased risk for various types of cancer, as well.[9477]<span style=\"font-size: 12pt;\">&nbsp;Some symptoms of the disease seem to vary according to the autoantibody involved in the disease.&nbsp;Myopathy occurs more often in patients with anti-Jo-1 or anti-PL-7; anti-Jo-1 is related to severe arthritis and \"mechanic's hand\", while anti-PL-12 with higher rates of Raynaud phenomenon; and anti-PL-7, anti-PL-12, anti-KS, and anti-OJ with cases of  ILD.[13330]<span style=\"color: #333333; font-family: Georgia, serif; font-size: 17px; letter-spacing: 0.102px; background-color: #fcfcfc;\">&nbsp;</span></span></p>","dateModified":"2017-04-17T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":9476,"authors":"Miller ML & Vleugels RA","articleTitle":"Clinical manifestations of dermatomyositis and polymyositis in adults","bookWebsiteJournalTitle":"UpToDate","date":"2016","volume":"","pages":"","url":"","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":9477,"authors":"","articleTitle":"Antisynthetase syndrome","bookWebsiteJournalTitle":"DermNet NZ","date":"December 2014","volume":"","pages":"","url":"http://dermnetnz.org/immune/antisynthetase.html","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":9478,"authors":"","articleTitle":"Antisynthetase syndrome","bookWebsiteJournalTitle":"Orphanet","date":"May 2014","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/Disease_Search.php?lng=EN&data_id=8611","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13330,"authors":"Esposito ACC, Gige TC & Miot HA","articleTitle":"Syndrome in question: antisynthetase syndrome (anti-PL-7)","bookWebsiteJournalTitle":"An Bras Dermatol","date":"2016","volume":"91(5)","pages":"683-685","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087238/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":699,"questionText":"What causes antisynthetase syndrome?","answerText":"The underlying cause of antisynthetase syndrome is currently unknown. However, it is considered an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000816.htm\" target=\"_blank\">autoimmune disease</a>. Autoimmune disorders occur when the body's <a href=\"http://www.nlm.nih.gov/medlineplus/immunesystemanddisorders.html\" target=\"_blank\">immune system</a> attacks and destroys healthy body tissue by mistake. In antisynthetase syndrome, specifically, the production of autoantibodies (<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002223.htm\" target=\"_blank\">antibodies</a> that attack normal cells instead of disease-causing agents) that recognize and attack certain <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002353.htm\" target=\"_blank\">enzymes</a> in the body called 'aminoacyl-tRNA synthetases' appears to be linked to the cause of the syndrome. Aminoacyl-tRNA synthetases are involved in <a href=\"http://ghr.nlm.nih.gov/handbook/howgeneswork/protein\" target=\"_blank\">protein</a> production within the body. These autoantibodies seem to appear after certain viral infections, drug exposure or in some people who already have a genetic predisposition. The exact role of&nbsp;autoantibodies&nbsp;in causing antisynthetase syndrome is not yet understood.[9477][9478]<br />\r\n<br />\r\nAminoacyl-tRNA synthase (ARS) autoantibodies &nbsp;associated with ASS include anti-Jo1 (anti-histidyl), &nbsp;anti-EJ (anti-glycyl), anti-OJ (anti-isoleucyl), anti-PL7 (anti-threonyl), anti-PL12 (anti-alanyl), anti-SC (anti-lysil), anti-KS (anti-asparaginyl), anti-JS (anti-glutaminyl), anti-Ha or anti-YRS (anti-threonyl), anti-tryptophanyl, and anti-Zo (anti-phenylalanyl) autoantibodies, with anti-Jo1 being the most common.[11592]<br />","dateModified":"2017-04-17T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":9477,"authors":"","articleTitle":"Antisynthetase syndrome","bookWebsiteJournalTitle":"DermNet NZ","date":"December 2014","volume":"","pages":"","url":"http://dermnetnz.org/immune/antisynthetase.html","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":9478,"authors":"","articleTitle":"Antisynthetase syndrome","bookWebsiteJournalTitle":"Orphanet","date":"May 2014","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/Disease_Search.php?lng=EN&data_id=8611","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11592,"authors":"Rojas-Serrano J, Herrera-Bringas D, Mejía M, Rivero H, Mateos-Toledo H & Figueroa JE","articleTitle":"Prognostic factors in a cohort of antisynthetase syndrome (ASS): serologic profile is associated with mortality in patients with interstitial lung disease (ILD).","bookWebsiteJournalTitle":"Clin Rheumatol","date":"September, 2015","volume":"34(9)","pages":"1563-9","url":"https://www.ncbi.nlm.nih.gov/pubmed/26219488","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":9257,"questionText":"How is antisynthetase syndrome diagnosed?","answerText":"A diagnosis of antisynthetase syndrome is often suspected based on the presence of characteristic <a href=\"https://rarediseases.info.nih.gov/gard/735/antisynthetase-syndrome/resources/9\" target=\"_blank\">signs and symptoms</a> once other conditions that cause similar features have been ruled out. Additional testing can then be ordered to confirm the diagnosis, determine the severity of the condition, and assist with determining treatment. This testing varies based on the signs and symptoms present in each person, but may include:[9477][9479]\r\n<ul>\r\n    <li>Blood tests to evaluate levels of muscle enzymes such as <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003504.htm\" target=\"_blank\">creatine kinase</a> and <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003566.htm\" target=\"_blank\">aldolase</a></li>\r\n    <li>Laboratory tests to look for the presence of autoantibodies associated with antisynthetase syndrome</li>\r\n    <li>High resolution <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003330.htm\" target=\"_blank\">computed tomography</a> (HRCT) of the lungs</li>\r\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003929.htm\" target=\"_blank\">Electromyography (EMG)</a></li>\r\n    <li>Muscle biopsy</li>\r\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003853.htm\" target=\"_blank\">Pulmonary function testing</a></li>\r\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003335.htm\" target=\"_blank\">Magnetic resonance imaging (MRI)</a> of affected muscles</li>\r\n    <li>Evaluation of swallowing difficulties and aspiration risk</li>\r\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003860.htm\" target=\"_blank\">Lung biopsy</a></li>\r\n</ul>\r\n<p class=\"bulletindent1\"><span>Not all patients with antisynthetase antibodies or even those classified as having the antisynthetase syndrome have all manifestations of this syndrome. Diagnosis is considered in patients with an antisynthetase antibody  plus two major criteria or one major criterion and two minor criteria:[9478][13330]<br />\r\n<br />\r\n<strong>Major criteria</strong>: <br />\r\n<br />\r\n1. Interstitial lung disease (not explained by environmental, occupational, medication exposure, and not related to any other base disease) <br />\r\n<br />\r\n2. Polymyositis or dermatomyositis  <br />\r\n<br />\r\n<strong>Minor criteria</strong>: <br />\r\n<br />\r\n1. Arthritis <br />\r\n<br />\r\n2. Raynaud phenomenon <br />\r\n<br />\r\n3. Mechanic's hand<br />\r\n</span></p>\r\n<br />","dateModified":"2017-04-17T00:00:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":9476,"authors":"Miller ML & Vleugels RA","articleTitle":"Clinical manifestations of dermatomyositis and polymyositis in adults","bookWebsiteJournalTitle":"UpToDate","date":"2016","volume":"","pages":"","url":"","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":9477,"authors":"","articleTitle":"Antisynthetase syndrome","bookWebsiteJournalTitle":"DermNet NZ","date":"December 2014","volume":"","pages":"","url":"http://dermnetnz.org/immune/antisynthetase.html","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":9479,"authors":"Chatterjee S, Prayson R, Farver C.","articleTitle":"Antisynthetase syndrome: not just an inflammatory myopathy","bookWebsiteJournalTitle":"Cleve Clin J Med","date":"October 2013","volume":"80(10)","pages":"655-666","url":"https://www.ncbi.nlm.nih.gov/pubmed/24085811","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13330,"authors":"Esposito ACC, Gige TC & Miot HA","articleTitle":"Syndrome in question: antisynthetase syndrome (anti-PL-7)","bookWebsiteJournalTitle":"An Bras Dermatol","date":"2016","volume":"91(5)","pages":"683-685","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087238/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":702,"questionText":"What treatment is available for antisynthetase syndrome?","answerText":"<a href=\"http://www.nlm.nih.gov/medlineplus/steroids.html\" target=\"_blank\">Corticosteroids</a> are typically the first-line of treatment and may be required for several months or years. These medications are often given orally; however, in severe cases, <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a601157.html\" target=\"_blank\">intravenous methylprednisolone</a> may be prescribe initially. Immunosuppressive medications may also be recommended, especially in people with severe muscle weakness or symptomatic <a href=\"http://www.nlm.nih.gov/medlineplus/interstitiallungdiseases.html\" target=\"_blank\">interstitial lung disease</a>.[9477][9479] According to recent studies,&nbsp;<a href=\"https://www.nlm.nih.gov/medlineplus/druginfo/meds/a607038.html\" target=\"_blank\">Rituximab</a> is the medication option when patients with lung disease do not respond well to other treatments.[11587] &nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/007448.htm\" target=\"_blank\">Physical therapy</a> is often necessary to improve weakness, reduce further muscle wasting from disuse, and prevent <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003185.htm\" target=\"_blank\">muscle contractures</a>.[9477][9479]","dateModified":"2016-05-26T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":9477,"authors":"","articleTitle":"Antisynthetase syndrome","bookWebsiteJournalTitle":"DermNet NZ","date":"December 2014","volume":"","pages":"","url":"http://dermnetnz.org/immune/antisynthetase.html","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":9479,"authors":"Chatterjee S, Prayson R, Farver C.","articleTitle":"Antisynthetase syndrome: not just an inflammatory myopathy","bookWebsiteJournalTitle":"Cleve Clin J Med","date":"October 2013","volume":"80(10)","pages":"655-666","url":"https://www.ncbi.nlm.nih.gov/pubmed/24085811","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11587,"authors":"Sharp C, McCabe M, Dodds N, Edey A, Mayers L, Adamali H, Millar AB & Gunawardena H","articleTitle":"Rituximab in autoimmune connective tissue disease-associated interstitial lung disease","bookWebsiteJournalTitle":"Rheumatology (Oxford)","date":"April 8, 2016","volume":"","pages":"pii: kew195","url":"https://www.ncbi.nlm.nih.gov/pubmed/27060110","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":700,"questionText":"What is the long-term outlook&nbsp;for people with&nbsp;antisynthetase syndrome?","answerText":"The long-term outlook (prognosis) for people with antisynthetase syndrome varies based on the severity of the condition and the signs and symptoms present. Although the condition is considered <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002312.htm\" target=\"_blank\">chronic</a> and often requires long-term treatment, those with muscle involvement as the only symptom are generally very responsive to treatment with <a href=\"http://www.nlm.nih.gov/medlineplus/steroids.html\" target=\"_blank\">corticosteroids</a> and/or immunosuppressive medications. When the lungs are affected, the severity and type of lung condition generally determines the prognosis.[9477][9478][9479] For example, patients with a progressive course of <a href=\"http://www.nlm.nih.gov/medlineplus/interstitiallungdiseases.html\" target=\"_blank\">interstitial lung disease</a> generally have a worse prognosis than those with a nonprogressive course, because respiratory failure is the main cause of death. However, in most cases the interstitial lung disease is nonprogressive.[11590]<br />\r\n<br />\r\n<span>Several studies have shown that the following factors may be associated with a worse prognosis:[9477][9479][11592]</span>\r\n<ul style=\"list-style-type: disc;\">\r\n    <li><span>Older age at onset (greater than 60 years)</span></li>\r\n    <li><span>Severity and extension of lung disease: The more severe and extensive lung involvement the worse the prognosis</span></li>\r\n    <li><span>Presence of malignancy (cancer)</span></li>\r\n    <li><span>Delay in diagnosis and treatment: Prognosis is better when the patients are treated early</span></li>\r\n    <li><span>Having a negative Jo1 antibody test: Several studies have shown that Jo1 status seems to be associated with prognosis, suggesting that non-Jo1 patients (patients who have other anti-ARS antibodies, that are non-Jo1) have worse survival rates than Jo1 patients.</span></li>\r\n</ul>\r\n<p><span> <br />\r\n<br />\r\n<span style=\"font-size: 17px; letter-spacing: 0.102px; background-color: #fcfcfc; font-family: Georgia, serif; color: #333333;\">&nbsp;</span></span></p>","dateModified":"2017-04-17T00:00:00","resourceClassificationName":"Prognosis","references":[{"referenceId":9477,"authors":"","articleTitle":"Antisynthetase syndrome","bookWebsiteJournalTitle":"DermNet NZ","date":"December 2014","volume":"","pages":"","url":"http://dermnetnz.org/immune/antisynthetase.html","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":9478,"authors":"","articleTitle":"Antisynthetase syndrome","bookWebsiteJournalTitle":"Orphanet","date":"May 2014","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/Disease_Search.php?lng=EN&data_id=8611","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":9479,"authors":"Chatterjee S, Prayson R, Farver C.","articleTitle":"Antisynthetase syndrome: not just an inflammatory myopathy","bookWebsiteJournalTitle":"Cleve Clin J Med","date":"October 2013","volume":"80(10)","pages":"655-666","url":"https://www.ncbi.nlm.nih.gov/pubmed/24085811","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11590,"authors":"Trallero-Araguás E& cols","articleTitle":"Clinical manifestations and long-term outcome of anti-Jo1 antisynthetase patients in a large cohort of Spanish patients from the GEAS-IIM group","bookWebsiteJournalTitle":"Semin Arthritis Rheum","date":"March 30, 2016","volume":"16","pages":"30001-4.","url":"https://www.ncbi.nlm.nih.gov/pubmed/27139168","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11592,"authors":"Rojas-Serrano J, Herrera-Bringas D, Mejía M, Rivero H, Mateos-Toledo H & Figueroa JE","articleTitle":"Prognostic factors in a cohort of antisynthetase syndrome (ASS): serologic profile is associated with mortality in patients with interstitial lung disease (ILD).","bookWebsiteJournalTitle":"Clin Rheumatol","date":"September, 2015","volume":"34(9)","pages":"1563-9","url":"https://www.ncbi.nlm.nih.gov/pubmed/26219488","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[{"relatedDiseaseId":9128,"relatedDiseaseName":"Idiopathic inflammatory myopathy","relation":"Parent","isRare":true,"hasGardPage":true}],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":4355,"phenoTypeName":"Autoimmunity","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":11831,"phenoTypeName":"Chest pain","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":9070,"phenoTypeName":"Cough","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":9419,"phenoTypeName":"Muscle weakness","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":3980,"phenoTypeName":"Myalgia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":6958,"phenoTypeName":"Myositis","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8076,"phenoTypeName":"Pulmonary fibrosis","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13725,"phenoTypeName":"Respiratory insufficiency","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8259,"phenoTypeName":"Edema","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10933,"phenoTypeName":"Elevated serum creatine kinase","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13575,"phenoTypeName":"EMG abnormality","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13043,"phenoTypeName":"Fever","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9359,"phenoTypeName":"Keratoconjunctivitis sicca","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":164,"phenoTypeName":"Lack of skin elasticity","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8716,"phenoTypeName":"Muscular hypotonia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":14207,"phenoTypeName":"Xerostomia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":4765,"phenoTypeName":"Abnormality of the voice","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8989,"phenoTypeName":"Aortic regurgitation","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13402,"phenoTypeName":"Dysphagia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5673,"phenoTypeName":"Joint dislocation","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":7992,"phenoTypeName":"Myocarditis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13290,"phenoTypeName":"Neoplasm","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8271,"phenoTypeName":"Pruritus","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13730,"phenoTypeName":"Pulmonary arterial hypertension","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8075,"phenoTypeName":"Recurrent respiratory infections","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8270,"phenoTypeName":"Skin rash","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":6924,"phenoTypeName":"Telangiectasia of the skin","frequencyText":"Occasional","percentRanges":"5%-29%"}],"medicalProducts":[],"EncodedName":"Antisynthetase_syndrome"}